News
-
-
-
COMMUNIQUÉ DE PRESSE
BRAIN Biotech AG: 3M FY 24/25 - Starting the year with double digit sales growth in the core BRAINBiocatalysts division
BRAIN Biotech AG reports 11% organic growth in Q1 of FY 24/25 for BRAINBiocatalysts, forecasts strong growth and solid EBITDA margin, maintains strong cash position of €17.8 million -
-
-
COMMUNIQUÉ DE PRESSE
Biological gold recycling: BRAIN Biotech AG collaborates with PX Group on the PX Urban Mining Initiative
BRAIN Biotech AG collaborates with PX Group on the PX Urban Mining Initiative for biological gold recycling, producing BioGold nuggets from local waste. Focus on sustainability -
-
-
COMMUNIQUÉ DE PRESSE
Annual Report 2023/24: BRAIN Biotech AG acts from a strong cash position and is confident about its growth prospects
BRAIN Biotech AG reports strong cash position & growth prospects in Annual Report 2023/24. Closed milestone transactions with Royalty Pharma & Akribion Therapeutics -